ACHE and Alzheimer disease: Three AChE inhibitors, namely, donepezil, galanthamine, and rivastigmine, and one fixed combination of donepezil and memantine (approved in 2014) are currently used as the main therapeutic option for AD treatment (Figure 1) [49,50].